Medtronic gave investors a glimpse Tuesday of its robotically assisted surgical system, a long-awaited set of products expected to debut in about two years. The system, known as the Hugo RAS (for robotic-assisted surgery), will be tested in clinical trials in the United States and elsewhere. ...
Read More at StarTribune - Minneapolis-St Paul